O'brien Stephanie Monaghan Insider Trades

Insider Trading History

Track insider trading activity for O'brien Stephanie Monaghan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$305k 7,441 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.13M 27,600 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$721k 17,580 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$236k 5,748 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$145k 3,544 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$5M 121,894 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$602k 14,684 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Tender)Reported as Tender on SEC Form 4.
$236k 5,750 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.13M 27,600 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$459k 11,199 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$351k 8,554 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $236k 5,750 shares
Last Trade
Apr 06, 2026 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$234k 5,750 shares
$40.63
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $602k 14,684 shares
Last Trade
Jan 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$369k 14,684 shares
$25.12
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $1.05M 25,666 shares
Last Trade
Jan 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$200k 7,961 shares
$25.12
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $726k 17,705 shares
Last Trade
Jan 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$357k 11,199 shares
$31.91
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $469k 11,438 shares
Last Trade
Jan 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$344k 5,748 shares
$59.86
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $174k 4,230 shares
Last Trade
Jan 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$200k 4,230 shares
$47.28
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $351k 8,554 shares
Last Trade
Jan 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$404k 8,554 shares
$47.28
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $1.13M 27,600 shares
Last Trade
Jan 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.58M 27,600 shares
$57.20
$41.03
Chinook Therapeutics
Chinook Therapeutics KDNY
Director
Holding Value $1.21M 30,000 shares
Last Trade
May 05, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$450k 30,000 shares
$15.00
$40.39

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up